首页> 外文学位 >Development of a multiplex PCR and recombinant vaccine against infectious bronchitis virus infection.
【24h】

Development of a multiplex PCR and recombinant vaccine against infectious bronchitis virus infection.

机译:抗传染性支气管炎病毒感染的多重PCR和重组疫苗的开发。

获取原文
获取原文并翻译 | 示例

摘要

Infectious bronchitis virus (IBV) causes an acute, highly contagious respiratory disease in chickens, which results in significant economic losses in commercial flocks. One of the major hurdles associated with the control of the disease is the continued emergence of new serotypes/variants due to mutation or recombination. This also makes the diagnosis of disease using conventional serological methods difficult. Therefore, there is a need for alternative vaccines and serotyping methods.; A multiplex PCR for Massachusetts and Arkansas serotypes of IBV was developed. Two serotype specific PCR products, 1026 bp for Massachusetts and 896 bp for Arkansas were amplified; the detection limits for both were 5 pg of viral RNA. By testing different isolates/serotypes of IBV and other avian bacterial and viral pathogens, the high specificity of the multiplex PCR was demonstrated. In addition, its ability to detect Massachusetts and Arkansas as co-infections was revealed.; To explore the potential use of recombinant vaccines in the control of IBV infections, recombinant fowlpox virus containing the S1 gene (rFPV-S1), and DNA vaccines containing the S1 (pBHCX402-S1) and S gene (pCMV-S) of IBV Massachusetts serotype were constructed. Expressions of the inserted genes were examined by SDS-PAGE and immunoblotting techniques and their protective immunity was evaluated in chickens. Results indicated that both S1 and S gene were expressed and IBV specific IgG and virus neutralization antibodies were detected in all groups vaccinated with (rFPV-S1), pBHCX402-S1 and pCMV-S. Although earlier immune response was detected in pCMV-S gene gun delivered group, no significant difference in the magnitude of immune response was found after three immunizations or 5 days post IBV challenge among the groups. Certain levels of protection manifested as preventing severe disease was achieved in all vaccinated groups, but not control groups. Furthermore, pCMV-S delivered by gene gun was much more efficacious, suggesting the DNA vaccination using S gene instead of S1 might provide better protection. The consecutive immunization of chickens with DNA vaccines and recombinant fowlpox virus of IBV did not have any enhanced effect on protective immunity. Overall, the potential use of the developed recombinant FPV and DNA vaccines against IBV infections was demonstrated.
机译:传染性支气管炎病毒(IBV)在鸡中引起急性,高度传染性的呼吸道疾病,导致商业鸡群遭受重大经济损失。与疾病控制有关的主要障碍之一是由于突变或重组而不断出现新的血清型/变异。这也使使用常规血清学方法诊断疾病变得困难。因此,需要替代疫苗和血清分型方法。开发了针对马萨诸塞州和阿肯色州血清型IBV的多重PCR。扩增了两种血清型特异性PCR产物,马萨诸塞州为1026 bp,阿肯色州为896 bp。两者的检出限均为5 pg病毒RNA。通过测试不同的IBV分离株/血清型以及其他禽细菌和病毒病原体,证明了多重PCR的高特异性。此外,还揭示了其检测马萨诸塞州和阿肯色州为共同感染的能力。为了探索重组疫苗在控制IBV感染中的潜在用途,含有S1基因的重组鸡痘病毒(rFPV-S1)和含有IBV马萨诸塞州的S1基因(pBHCX402-S1)和S基因的DNA疫苗(pCMV-S)血清型被构建。通过SDS-PAGE和免疫印迹技术检查插入基因的表达,并在鸡中评估其保护性免疫。结果表明,在接种了(rFPV-S1),pBHCX402-S1和pCMV-S的所有组中,均表达了S1和S基因,并检测到IBV特异性IgG和病毒中和抗体。尽管在pCMV-S基因枪支递送组中检测到较早的免疫应答,但是在各组之间进行3次免疫或IBV攻击后5天后,发现免疫应答的大小没有显着差异。在所有接种组中,但未在对照组中,均达到一定程度的保护作用,可预防严重疾病。此外,基因枪传递的pCMV-S更为有效,这表明使用S基因而非S1进行DNA疫苗接种可能提供更好的保护。用DNA疫苗和IBV重组禽痘病毒连续免疫鸡对保护性免疫没有任何增强作用。总的来说,已证明了开发的重组FPV和DNA疫苗对IBV感染的潜在用途。

著录项

  • 作者

    Wang, Xiuqing.;

  • 作者单位

    The University of Connecticut.;

  • 授予单位 The University of Connecticut.;
  • 学科 Biology Microbiology.; Biology Molecular.; Biology Veterinary Science.; Health Sciences Immunology.
  • 学位 Ph.D.
  • 年度 2000
  • 页码 117 p.
  • 总页数 117
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 微生物学;分子遗传学;动物学;预防医学、卫生学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号